AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34334434 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 11
Study 34334434 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS
Number of subjects: 11
Study 33455099 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral therapy
Number of subjects: 132
Study 33455099 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 132
Study 33669930 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-driven automated medical-history-taking systems with AI-driven differential-diagnosis lists
Number of subjects: 22
Study 33669930 — intervention group
Group type: COMPARATOR
Intervention: AI-driven automated medical-history-taking systems without AI-driven differential-diagnosis lists
Number of subjects: 22
Study 33564872 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoglycerides (MAGs)
Number of subjects: 22
Study 33564872 — intervention group
Group type: COMPARATOR
Intervention: Ethyl Esters (EEs)
Number of subjects: 22
Study 33564872 — intervention group
Group type: COMPARATOR
Intervention: Triglycerides (TGs)
Number of subjects: 22
Study 33564872 — intervention group
Group type: COMPARATOR
Intervention: All supplements (MAGs, EEs, TGs)
Number of subjects: 22
Study 35917580 — intervention group
Group type: EXPERIMENTAL
Intervention: R‐Vera 300 mg/day
Number of subjects: 184
Study 35917580 — intervention group
Group type: EXPERIMENTAL
Intervention: R‐Vera 450 mg/day
Number of subjects: 184
Study 35917580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study 34217769 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracranial Hemorrhage (ICH) identified in infants
Number of subjects: 883
Study 34217769 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Grade 2, Grade 3, or Grade 4 ICH at day 7-9
Number of subjects: 883
Study 34217769 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Grade 2, any Grade 3, and any Grade 4 ICH at 7-9 days or 36 weeks
Number of subjects: 883
Study 34217769 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal steroids (2 or more doses)
Number of subjects: 883
Study 34217769 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple gestation and cesarean delivery
Number of subjects: 883
Study 32829942 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous Plantar Myofascial Mobilization (PMM)
Number of subjects: 42
Study 34156651 — intervention group
Group type: EXPERIMENTAL
Intervention: CoRE + real tDCS
Number of subjects: 33
Study 34156651 — intervention group
Group type: COMPARATOR
Intervention: CoRE + sham tDCS
Number of subjects: 33
Study 34103316 — intervention group
Group type: EXPERIMENTAL
Intervention: SPAIRE approach
Number of subjects: 228
Study 36344910 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA/PCIA
Number of subjects: 86
Study 36344910 — intervention group
Group type: COMPARATOR
Intervention: TEA
Number of subjects: 86
Study 32440935 — intervention group
Group type: EXPERIMENTAL
Intervention: Corifollitropin-α late-start (day 4)
Number of subjects: 0
Study 32440935 — intervention group
Group type: COMPARATOR
Intervention: Standard administration (day 2)
Number of subjects: 0
Study 34350678 — intervention group
Group type: EXPERIMENTAL
Intervention: Robust semiparametric logistic model
Number of subjects: 0
Study 34350678 — intervention group
Group type: COMPARATOR
Intervention: Classic logistic model
Number of subjects: 0
Study 34525006 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 300
Study 34525006 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-IFNγ cytokine responses
Number of subjects: 300
Study 34525006 — intervention group
Group type: COMPARATOR
Intervention: QFT-Plus
Number of subjects: 300
Study 35529264 — intervention group
Group type: EXPERIMENTAL
Intervention: Humanistic care combined with predictive nursing
Number of subjects: 90
Study 35529264 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 90
Study 33648489 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered tests for chronic PGP assessment
Number of subjects: 289
Study 33648489 — intervention group
Group type: COMPARATOR
Intervention: Self-administered tests
Number of subjects: 289
Study 33648489 — intervention group
Group type: COMPARATOR
Intervention: Self-administered tests vs. clinical examination tests
Number of subjects: 289
Study 35485068 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexidol 125 mg twice daily
Number of subjects: 333
Study 35485068 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexidol 125 mg daily + placebo
Number of subjects: 333
Study 35485068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333
Study 33856821 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine metabolite ratio (NMR) calculated as the ratio of plasma cotinine and trans‐3' hydroxycotinine, log-transformed.
Number of subjects: 244
Study 35322973 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency (10 Hz) repetitive transcranial magnetic stimulation (rTMS), 5 sessions
Number of subjects: 22
Study 35322973 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 22
Study 36480390 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol PRS in no-pain condition (Black participants)
Number of subjects: 209
Study 36480390 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain PRS in no-pain condition (White participants)
Number of subjects: 209
Study 36480390 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain PRS in pain condition (White participants)
Number of subjects: 209
Study 36480390 — intervention group
Group type: COMPARATOR
Intervention: Alcohol PRS (White participants)
Number of subjects: 209
Study 33545763 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day gradual early functional exercise program
Number of subjects: 106
Study 33545763 — intervention group
Group type: COMPARATOR
Intervention: Routine functional exercises
Number of subjects: 106
Study 32468916 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylurea treatment
Number of subjects: 0
Study 32468916 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylurea-induced hypoglycemia
Number of subjects: 0
Study 36353135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-motor dual-task (CMDT) training
Number of subjects: 40
Study 36353135 — intervention group
Group type: COMPARATOR
Intervention: Cognitive task (CT) training
Number of subjects: 40
Study 34019710 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular fitness
Number of subjects: 92
Study 34019710 — intervention group
Group type: EXPERIMENTAL
Intervention: Gross motor skills
Number of subjects: 92
Study 34019710 — intervention group
Group type: EXPERIMENTAL
Intervention: White matter microstructure (FA, AD, RD)
Number of subjects: 92
Study 35241222 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 1414
Study 35241222 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1414
Study 34710229 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital infrared thermal imaging (DITI)
Number of subjects: 224
Study 34710229 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 224
Study 32821038 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional negative-pressure wound therapy (n=785)
Number of subjects: 1548
Study 32821038 — intervention group
Group type: COMPARATOR
Intervention: Standard dressings (n=763)
Number of subjects: 1548
Study 34503198 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 40
Study 34503198 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 40
Study 34503198 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 40
Study 32919196 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite dimension 'Pain or Discomfort' (P/D) in self-reporting health.
Number of subjects: 2422
Study 32919196 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite dimension 'Anxiety or Depression' (A/D) in self-reporting health.
Number of subjects: 2422
Study 32919196 — intervention group
Group type: EXPERIMENTAL
Intervention: Valuation of stylised EQ-5D states using Discrete Choice Experiments.
Number of subjects: 2422
Study 32919196 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite dimension 'Pain or Discomfort' (P/D) in valuation.
Number of subjects: 2422
Study 32919196 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite dimension 'Anxiety or Depression' (A/D) in valuation.
Number of subjects: 2422
Study 35608027 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (twice a week for 30 minutes for 8 weeks)
Number of subjects: 12
Study 35608027 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 12
Study 33677183 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine
Number of subjects: 1523
Study 33677183 — intervention group
Group type: EXPERIMENTAL
Intervention: MADRS severity thresholds
Number of subjects: 1523
Study 33677183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1523
Study 32016122 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive Interdisciplinary Self-Management (PRISMA) program with usual care
Number of subjects: 203
Study 32016122 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 203
Study 36451471 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin/ezetimibe
Number of subjects: 108
Study 36451471 — intervention group
Group type: COMPARATOR
Intervention: rosuvastatin
Number of subjects: 108
Study 35570662 — intervention group
Group type: EXPERIMENTAL
Intervention: Impending pain condition
Number of subjects: 122
Study 35570662 — intervention group
Group type: COMPARATOR
Intervention: Impending touch condition
Number of subjects: 122
Study 34285247 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 101
Study 34285247 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 101
Study 32291702 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery (ERAS)
Number of subjects: 112
Study 32291702 — intervention group
Group type: COMPARATOR
Intervention: Standard Recovery Pathway
Number of subjects: 112
Study 32185995 — intervention group
Group type: EXPERIMENTAL
Intervention: Danggui Sini plus Wuzhuyu Shengjiang Tang (DSWST)
Number of subjects: 25
Study 32185995 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 25
Study 34593311 — intervention group
Group type: EXPERIMENTAL
Intervention: NHFOV therapy
Number of subjects: 150
Study 34593311 — intervention group
Group type: COMPARATOR
Intervention: NIPPV therapy
Number of subjects: 150
Study 34515589 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated position
Number of subjects: 42
Study 34515589 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 42
Study 34515589 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 42
Study 34515589 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest reliability in supine position
Number of subjects: 42
Study 34515589 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest reliability in seated position
Number of subjects: 42
Study 34515589 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest reliability in standing position
Number of subjects: 42
Study 34299895 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamically tailored exergame (based on an accelerometer sensor integrated in a T-shirt)
Number of subjects: 94
Study 34299895 — intervention group
Group type: COMPARATOR
Intervention: Non-tailored exergame
Number of subjects: 94
Study 33093947 — intervention group
Group type: EXPERIMENTAL
Intervention: Acalabrutinib in combination with R-CHOP
Number of subjects: 39
Study 33168602 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (0.05 mg/kg twice-daily) plus low-dose corticosteroid (0.5 mg/kg prednisolone once-daily)
Number of subjects: 144
Study 33168602 — intervention group
Group type: COMPARATOR
Intervention: High-dose corticosteroid (1 mg/kg prednisolone once-daily)
Number of subjects: 144
Study 33168602 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance tacrolimus (3-8 ng/ml) plus tapered steroid
Number of subjects: 144
Study 33168602 — intervention group
Group type: COMPARATOR
Intervention: Tapered steroid alone
Number of subjects: 144
Study 36098857 — intervention group
Group type: EXPERIMENTAL
Intervention: Arbuscular mycorrhizal fungi (Glomus mosseae)
Number of subjects: 3
Study 36098857 — intervention group
Group type: COMPARATOR
Intervention: Cadmium concentrations (0, 10, 25, 50, 75 and 100 mg kg‐1)
Number of subjects: 3
Study 32387721 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic memory ability
Number of subjects: 205
Study 32387721 — intervention group
Group type: COMPARATOR
Intervention: Working memory capacity
Number of subjects: 205
Study 34986782 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group received 12-15 hours of training for providers.
Number of subjects: 34
Study 34986782 — intervention group
Group type: COMPARATOR
Intervention: Control providers received six webinars on early development.
Number of subjects: 34
Study 34105881 — intervention group
Group type: EXPERIMENTAL
Intervention: severe ETW (s-ETW, lemon juice/pH:2.5/4.25%wt/vol citric acid)
Number of subjects: 20
Study 34105881 — intervention group
Group type: EXPERIMENTAL
Intervention: moderate ETW (m-ETW, grapefruit juice/pH:3.5/1.03%wt/vol citric acid)
Number of subjects: 20
Study 34105881 — intervention group
Group type: COMPARATOR
Intervention: non-ETW (water)
Number of subjects: 20
Study 32498534 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Number of subjects: 64
Study 32498534 — intervention group
Group type: COMPARATOR
Intervention: Control (without dexrazoxane)
Number of subjects: 64
Study 33155711 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS intervention (n=230)
Number of subjects: 462
Study 33155711 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) (n=232)
Number of subjects: 462
Study 33155711 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS intervention
Number of subjects: 462
Study 33155711 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 462
Study 34941300 — intervention group
Group type: EXPERIMENTAL
Intervention: Taekwondo intervention (11-week beginners' course)
Number of subjects: 240
Study 35051323 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's powered toothbrush
Number of subjects: 55
Study 35051323 — intervention group
Group type: COMPARATOR
Intervention: Children's manual toothbrush
Number of subjects: 55
Study 32798490 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab, vemurafenib, and cobimetinib
Number of subjects: 0
Study 32798490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35550672 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture containing four strains of Bifidobacterium species and one Lacticaseibacillus strain, administered daily, dosage not specified, duration not specified.
Number of subjects: 0
Study 32443684 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula containing BMOS
Number of subjects: 203
Study 32443684 — intervention group
Group type: COMPARATOR
Intervention: Control formula
Number of subjects: 203
Study 32443684 — intervention group
Group type: EXPERIMENTAL
Intervention: All formula groups
Number of subjects: 203
Study 35533640 — intervention group
Group type: EXPERIMENTAL
Intervention: Salinity-resistant ecotypes (e.g., 'AE5')
Number of subjects: 6
Study 35533640 — intervention group
Group type: COMPARATOR
Intervention: Salinity-susceptible ecotypes (e.g., 'AE3')
Number of subjects: 6
Study 34508672 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 15
Study 34508672 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 15
Study 35979056 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led health education based on the knowledge, belief, and practice model
Number of subjects: 60
Study 32859933 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT) from healthy donors
Number of subjects: 20
Study 32859933 — intervention group
Group type: COMPARATOR
Intervention: Placebo FMT (vehicle only)
Number of subjects: 20
Study 35772250 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-guided anesthesia (EEG-G)
Number of subjects: 200
Study 35772250 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 200
Study 35772250 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-guided anesthesia (EEG-G) and Standard care (SC)
Number of subjects: 200
Study 34269090 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematology/oncology drugs with pediatric label changes
Number of subjects: 49
Study 34269090 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematology/oncology drugs with pediatric indications
Number of subjects: 49
Study 34269090 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematology/oncology drugs that failed to receive pediatric indications
Number of subjects: 49
Study 32473356 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg loading dose
Number of subjects: 1900
Study 32473356 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (300 or 600 mg loading dose)
Number of subjects: 1900
Study 32473356 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily for 30 days
Number of subjects: 1900
Study 32473356 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75 mg once daily for 30 days
Number of subjects: 1900
Study 34961496 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on health belief model
Number of subjects: 200
Study 34961496 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study 32067096 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-high-fidelity (UHF) VR simulation training
Number of subjects: 24
Study 32067096 — intervention group
Group type: COMPARATOR
Intervention: Conventional, screen-based VR simulation training (cVR)
Number of subjects: 24
Study 33581295 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisite injection therapy (2 mL of triamcinolone acetonide, 4 mL of bupivacaine, and 34 mL of saline solution)
Number of subjects: 76
Study 33581295 — intervention group
Group type: COMPARATOR
Intervention: Single injection therapy (1 mL of triamcinolone acetonide and 2 mL of bupivacaine)
Number of subjects: 76
Study 33581295 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisite injection therapy
Number of subjects: 76
Study 33581295 — intervention group
Group type: COMPARATOR
Intervention: Single injection therapy
Number of subjects: 76
Study 35413116 — intervention group
Group type: EXPERIMENTAL
Intervention: Idasanutlin 300 mg plus cytarabine 1 g/m2 IV on days 1 to 5 of 28-day cycles
Number of subjects: 447
Study 35413116 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus cytarabine 1 g/m2 IV on days 1 to 5 of 28-day cycles
Number of subjects: 447
Study 35413116 — intervention group
Group type: EXPERIMENTAL
Intervention: Idasanutlin plus cytarabine
Number of subjects: 447
Study 35413116 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus cytarabine
Number of subjects: 447
Study 33650303 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy (APM)
Number of subjects: 287
Study 33650303 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT)
Number of subjects: 287
Study 36302345 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted Lung Denervation (TLD)
Number of subjects: 20
Study 36302345 — intervention group
Group type: COMPARATOR
Intervention: Sham bronchoscopy
Number of subjects: 20
Study 34941132 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline-containing regimen
Number of subjects: 284
Study 34941132 — intervention group
Group type: COMPARATOR
Intervention: Furazolidone-containing regimen
Number of subjects: 284
Study 34535176 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin intravenous drip (Group A)
Number of subjects: 136
Study 34535176 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine on the basis of cisplatin (Group B)
Number of subjects: 136
Study 32023995 — intervention group
Group type: EXPERIMENTAL
Intervention: Active and Healthy Kids program (120 min/week of physically active learning and 25 min/week of physical active breaks)
Number of subjects: 644
Study 32023995 — intervention group
Group type: COMPARATOR
Intervention: Control group (9 schools, 135 min/week of physical education)
Number of subjects: 644
Study 32023995 — intervention group
Group type: EXPERIMENTAL
Intervention: Active and Healthy Kids program (for girls)
Number of subjects: 644
Study 36308441 — intervention group
Group type: EXPERIMENTAL
Intervention: Calmangafodipir (CaM) 5 μmol/kg
Number of subjects: 592
Study 36308441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 592
Study 33341226 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) with usual care (UC)
Number of subjects: 108
Study 33341226 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 108
Study 32692493 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) administration as a bolus followed by continuous infusion
Number of subjects: 7
Study 32692493 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) administration
Number of subjects: 7
Study 35393916 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality dementia tour
Number of subjects: 41
Study 35393916 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical-based dementia tour
Number of subjects: 41
Study 35393916 — intervention group
Group type: COMPARATOR
Intervention: Reading strengths-focused case studies
Number of subjects: 41
Study 33839788 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination exercise (COMB)
Number of subjects: 160
Study 33839788 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AEX)
Number of subjects: 160
Study 33839788 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (REX)
Number of subjects: 160
Study 33839788 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study 32206903 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic exenatide
Number of subjects: 240
Study 32206903 — intervention group
Group type: COMPARATOR
Intervention: Branded exenatide
Number of subjects: 240